1Peres LA, Percio PP. Mineral and bone disorder and vascular calci-fication in patients with chronic kidney diseas [ J]. 2014,36 (2 ):201 -207.
2Hagar Meltzer,Moran Milrad,Ori Brenner,et al. The Effect of Natu-rally Occurring Chronic Kidney Disease on the Micro - Structuraland Mechanical Properties of Bone [ J]. PLoS One,2014,9 ( 10 );el 10057.
4Gutierrez OM, Januzzi JL,Isakova T,et al. Fibroblast grrowth fac-tor23 and left ventricular hypertrophy in chronic kidney disease[J]. Circulation,2009,119(19) :2545 -2552.
5Hruska kA,Mathew S. The roles of the skeleton and phosphorus inthe CKD mineral bone disorder[ J]. Adv Chronic kidney Dis,2011,18(2):98-104.
6Makoto Kuro - o. Phosphate, Klotho [ J ]. Kidney International,2011,79:S20-S23.
7Ben - Dov IZ,Galitzer H,Lavi - Moshayoff V,et al. The parathyroidis a target organ for FGF23 in rats [ J ]. JClin Invest, 2007 , 117 :4003 -4008.
8Isakova T, Wahl P, Vargas GS,et al. Fibroblast growth ?actor23 iselevated before parathyroid hormone and phosphate in chronic kid-ney disease[ J]. Kidney Int,2011,79( 12) : 1370 - 1378.
9Sapir - Koren H,Livshits G. Bone mineralization and regulation ofphosphate homestasis[ J]. IBMS BoneKEy,2011,8:286 -300.
10Yu Y,Sanderson SR. Novel NaPi - lie mutations causing HHRHand idiopathic hypercalciuria in several unrelated families: long -term follow - up in one kindred[ J]. Bone,2012,50(5) : 1100 -1106.
